Tusaldah Limited vs Welcure Drugs Pharmaceuticals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Tusaldah Limited is ₹ 118.95 as of 23 Oct 15:30 . The P/E Ratio of Tusaldah Limited changed from 0.8 on March 2022 to 0 on March 2026 . This represents a CAGR of -100.00% over 5 yearsThe P/E Ratio of Welcure Drugs & Pharmaceuticals Ltd changed from 37.6 on March 2021 to 0 on March 2026 . This represents a CAGR of -100.00% over 6 years The Market Cap of Tusaldah Limited changed from ₹ 1.07 crore on March 2022 to ₹ 24.78 crore on March 2026 . This represents a CAGR of 87.48% over 5 yearsThe Market Cap of Welcure Drugs & Pharmaceuticals Ltd changed from ₹ 2.54 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of -100.00% over 6 years The revenue of Tusaldah Limited for the Jun '26 is ₹ 1.56 crore as compare to the Mar '26 revenue of ₹ 2.9 crore. This represent the decline of -46.21% The revenue of Welcure Drugs & Pharmaceuticals Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Tusaldah Limited for the Jun '26 is ₹ -0.13 crore as compare to the Mar '26 ebitda of ₹ -0.13 crore. This represent the decline of 0% The ebitda of Welcure Drugs & Pharmaceuticals Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ -49.86 crore. This represent the decline of -100% The net profit of Tusaldah Limited changed from ₹ -0.07 crore to ₹ -0.15 crore over 9 quarters. This represents a CAGR of 40.32% The net profit of Welcure Drugs & Pharmaceuticals Ltd changed from ₹ -0.34 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of -100.00% The Dividend Payout of Tusaldah Limited changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Welcure Drugs & Pharmaceuticals Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Tusaldah Limited

Tusaldah Limited was initially established as High Street Filatex Limited in 1994 and the name of the Company was changed to Tusaldah Limited in August 2025.
It is engaged in Trading of Knitted Socks, head band and wrist band and trading in yarn and commodities. The Company harbors extensive expansion plans and is geared of install 100 more machines in a short while, for which the constructions of new factory is going in full swing.
It has most strategically located plant and has adopted advanced production techniques.
It is capable of making socks of different designs/patterns.

About Welcure Drugs & Pharmaceuticals Ltd

Incorporated on 4th June, 1992, Welcure Drugs And Pharmaceuticals Limited(WDPL) was promoted by D C Jain, Sanjeev Jain and Sandeep Jain.
The promoters have interests in other companies such as Paam Pharmaceuticals, Pioneer Products, Alirox Abrasives, A K Laboratories, etc. WDPL had come out with a Rs 4-cr public issue in Aug.'94 to part-finance the Rs 12 Crore project to manufacture bulk drugs in Rajasthan and finance investments in a subsidiary, A K Laboratories (AKL).
The company has also submitted the letter of offer for a Rs 7.09-cr rights issue of equity shares in Jan.'96 to finance its expansion programmes. Products of WDPL include bulk drugs such as ampicillin and trimethoprim, drugs intermediates and pharmaceutical formulations.
It has decided to add amoxycillin and cloxacillin to its range with provision to manufacture ibuprofen.

FAQs for the comparison of Tusaldah Limited and Welcure Drugs & Pharmaceuticals Ltd

Which company has a larger market capitalization, Tusaldah Limited or Welcure Drugs & Pharmaceuticals Ltd?

Market cap of Tusaldah Limited is 27 Cr while Market cap of Welcure Drugs & Pharmaceuticals Ltd is 22 Cr

What are the key factors driving the stock performance of Tusaldah Limited and Welcure Drugs & Pharmaceuticals Ltd?

The stock performance of Tusaldah Limited and Welcure Drugs & Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Tusaldah Limited and Welcure Drugs & Pharmaceuticals Ltd?

As of October 25, 2026, the Tusaldah Limited stock price is INR ₹118.95. On the other hand, Welcure Drugs & Pharmaceuticals Ltd stock price is INR ₹0.18.

How do dividend payouts of Tusaldah Limited and Welcure Drugs & Pharmaceuticals Ltd compare?

To compare the dividend payouts of Tusaldah Limited and Welcure Drugs & Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.